Vol. 20 No. 5 (2022): Blood Transfusion - 5 2022 (September-October)
Original article
-
SARS-CoV-2 seroprevalence in blood donors before and after the first wave in Catalonia (Spain)
-
SARS-CoV-2 and post-donation information: a one-year experience of the French haemovigilance network
-
Associations of anaemia and race with peripartum transfusion in three United States datasets
-
Expanding restrictive transfusion evidence in surgical practice: a multicentre, prospective cohort study
-
Assessing quality of blood components derived from whole blood treated with riboflavin and ultraviolet light and separated with a fully automated device
-
Immuno-hematological monitoring after allogeneic stem cell transplantation: a single-center, prospective study of 104 patients
-
Analysis of the molecular mechanism and pedigree investigation of para-Bombay phenotype caused by combined mutations at position h649 and h768 of FUT1 gene
-
Anti-SARS-CoV-2 vaccination does not influence anticoagulation levels in stable long-term warfarin treatment
Announcements
Winter Closure
The Editorial Office will be closed from December 31 to January 7, 2026.
Season’s greetings to all our readers, authors, and reviewers.
Read moreSIMTI 2026
46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)
Read moreSETS 2026
35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).Madrid, 4-6 June 2026.
Read moreEditorial Office Closure Notice
Please note that the BT Editorial Office will be closed until August 26, 2026.
During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.
Thank you for your understanding.
Best regards,
BT Editorial Office
Read more
Impact Factor 2025
We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.
Read more